Eisai Co., Ltd. (ESALF)
OTCMKTS
· Delayed Price · Currency is USD
26.00
0.00 (0.00%)
May 19, 2025, 4:00 PM EDT
Eisai Employees
Eisai had 11,067 employees as of March 31, 2024. The number of employees decreased by 9 or -0.08% compared to the previous year.
Employees
11,067
Change (1Y)
-9
Growth (1Y)
-0.08%
Revenue / Employee
$476,328
Profits / Employee
$28,017
Market Cap
7.51B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 64 |
| CytoDyn | 9 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Eisai News
- 5 days ago - Eisai Co., Ltd. (ESALF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Eisai Co., Ltd. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 5 days ago - Eisai GAAP EPS of ¥163.76, revenue of ¥789.4B; initiates FY outlook - Seeking Alpha
- 4 weeks ago - Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion - Benzinga
- 4 weeks ago - Biogen/ Eisai win EU approval for Alzheimer’s therapy - Seeking Alpha
- 5 weeks ago - EU authorizes Eisai-Biogen's drug for treatment of early Alzheimer's disease - Reuters
- 6 weeks ago - Japanese Stocks Rise With Market Focused on U.S. Trade News - Barron's
- 2 months ago - LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer's Treatments| DelveInsight - Benzinga